11,943 Shares in Astrana Health, Inc. (NASDAQ:ASTH) Bought by Guidance Capital Inc.

Guidance Capital Inc. bought a new position in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 11,943 shares of the company's stock, valued at approximately $724,000.

Several other institutional investors also recently modified their holdings of ASTH. GAMMA Investing LLC acquired a new stake in Astrana Health during the 3rd quarter worth approximately $34,000. Central Pacific Bank Trust Division bought a new position in shares of Astrana Health during the third quarter valued at $160,000. Everence Capital Management Inc. acquired a new position in shares of Astrana Health during the third quarter worth $272,000. Granite Bay Wealth Management LLC bought a new stake in shares of Astrana Health in the third quarter worth $290,000. Finally, Handelsbanken Fonder AB acquired a new stake in Astrana Health in the third quarter valued at $492,000. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Astrana Health Stock Down 5.6 %

Shares of ASTH traded down $3.24 during trading hours on Wednesday, hitting $54.66. The stock had a trading volume of 240,252 shares, compared to its average volume of 197,983. Astrana Health, Inc. has a 1-year low of $28.86 and a 1-year high of $63.20. The firm has a market capitalization of $3.06 billion, a P/E ratio of 41.41, a price-to-earnings-growth ratio of 2.20 and a beta of 1.21. The firm has a 50 day simple moving average of $53.78 and a 200-day simple moving average of $46.19. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.84 and a quick ratio of 1.84.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $0.40 EPS for the quarter, beating analysts' consensus estimates of $0.39 by $0.01. Astrana Health had a return on equity of 10.71% and a net margin of 4.30%. The firm had revenue of $486.30 million during the quarter, compared to analysts' expectations of $440.68 million. During the same quarter last year, the firm posted $0.28 earnings per share. The company's revenue for the quarter was up 39.7% compared to the same quarter last year. Sell-side analysts predict that Astrana Health, Inc. will post 1.33 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have issued reports on the stock. Robert W. Baird raised their price target on shares of Astrana Health from $54.00 to $67.00 and gave the stock an "outperform" rating in a report on Thursday, August 15th. Stifel Nicolaus boosted their target price on shares of Astrana Health from $48.00 to $60.00 and gave the company a "buy" rating in a report on Thursday, August 1st. BTIG Research increased their price target on Astrana Health from $60.00 to $70.00 and gave the stock a "buy" rating in a report on Thursday, October 3rd. KeyCorp began coverage on Astrana Health in a research report on Friday, October 11th. They issued a "sector weight" rating for the company. Finally, Truist Financial upped their target price on Astrana Health from $50.00 to $59.00 and gave the company a "buy" rating in a research report on Friday, August 9th. One equities research analyst has rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $62.00.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.